Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF SHARE BASED AWARDS (Details)

v3.22.2.2
SCHEDULE OF SHARE BASED AWARDS (Details)
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Equity [Abstract]  
Number of options, outstanding, ending balance | shares 450,000
Weighted average exercise price, ending balance | $ / shares $ 1.38
Weighted Average Remaining Contractual Term (years), Outstanding Balance 4 years 1 month 6 days
Number of options, exercisable, ending balance | shares 250,000
Weighted average exercise price, ending balance | $ / shares $ 1.72
Weighted Average Remaining Contractual Term (years), Exercisable Balance 4 years 1 month 6 days